Barbanti-Brodano Giovanni, Girolami Marco, Ghermandi Riccardo, Terzi Silvia, Gasbarrini Alessandro, Bandiera Stefano, Boriani Stefano
Department of Oncological and Degenerative Spine Surgery, Istituto Ortopedico Rizzoli, Via G.C. Pupilli, 40136, Bologna, Italy.
Eur Spine J. 2017 May;26(Suppl 1):158-166. doi: 10.1007/s00586-017-4978-x. Epub 2017 Feb 6.
ABC is a benign lesion with unpredictable behavior. Its treatment is challenging, especially in poorly accessible surgical areas, such as spine and pelvis. Currently, the first-line treatment of ABC is repeated selective arterial embolization (SAE) until healing. Other options have been used with variable success rates. We propose an alternative treatment for spine aneurysmal bone cyst (sABC) based on the injection of concentrated autologous bone marrow.
We retrospectively report and analyze here two cases of patients, a 14-year-old girl and a 16-year-old boy, both affected by ABC in C2 vertebra which were impossible to treat by SAE. They were treated with single or repeated injection of concentrated autologous bone marrow into the lesion. Their follow-up period is 27 months for both patients.
In the two cases reported here we observed a progressive ossification of the lesion, which was slow in one case, requiring three subsequent injections of concentrated bone marrow, and fast in the other case, beginning 1 month after the procedure. In both cases, the healing of the lesion was associated with symptom relief and the clinical status of the patients remains stable after 2 years.
Although SAE can still be considered the first line in the treatment of ABC in the axial skeleton, new promising therapeutic procedures involving the use of mesenchymal stem cells are developing.
动脉瘤样骨囊肿(ABC)是一种行为不可预测的良性病变。其治疗具有挑战性,尤其是在难以触及的手术区域,如脊柱和骨盆。目前,ABC的一线治疗方法是反复进行选择性动脉栓塞(SAE)直至愈合。其他治疗方法的成功率各不相同。我们提出了一种基于注射浓缩自体骨髓的脊柱动脉瘤样骨囊肿(sABC)替代治疗方法。
我们在此回顾性报告并分析了两例患者,一名14岁女孩和一名16岁男孩,均患有C2椎体的ABC,无法通过SAE治疗。他们接受了单次或反复向病变部位注射浓缩自体骨髓的治疗。两名患者的随访期均为27个月。
在本文报告的两例病例中,我们观察到病变逐渐骨化,其中一例进展缓慢,需要随后三次注射浓缩骨髓,另一例进展迅速,在手术后1个月开始。在两例病例中,病变愈合均伴随着症状缓解,且患者的临床状况在2年后保持稳定。
尽管SAE仍可被视为轴向骨骼ABC治疗的一线方法,但涉及使用间充质干细胞的新的有前景的治疗方法正在不断发展。